Targeted Testing and Treatment of Latent TB Infection: An Online Presentation

Supplemental Materials

Downloadable Files
Recommended Websites
Recommended Readings
References

Downloadable Files:

Recommended Websites:

Recommended Readings:

Targeted Testing of TB

Centers for Disease Control and Prevention. Fact Sheet : Tuberculin Skin Testing
http://www.cdc.gov/tb/publications/factsheets/testing/skintesting.htm

Centers for Disease Control and Prevention. Mantoux Tuberculin Skin Test Training: Facilitator's Guide
http://www.cdc.gov/tb/education/Mantoux/guide.htm

Centers for Disease Control and Prevention. Mantoux Tuberculin Skin Testing - DVD Kit (order form)
http://wwwn.cdc.gov/pubs/tb.aspx

Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49 (RR-6): 1-51.

Cain KP, Benoit SR, Wonston CA, Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA 2008;300(4):405-412.

Diel R, Loddenkemper R, Nienhaus A. Evidence based comparison of commercial interferon-gamma release assays for detecting active tuberculosis -- a meta-analysis. Chest. 2009 Dec 18. [Epub ahead of print]

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008 Jul 15;5(7):e152

Lin HH, Ezzati M, Murray MB. Tobacco smoke, indoor pollution, and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4(1): 173-189.

Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med. 2008;149(3):177-84

Underwood BR, White VL, Baker T, Law M, Moore-Gillon JC. Contact tracing and population screening for tuberculosis--who should be assessed? J Public Health Med. Mar 2003;25(1):59-61.

Treatment of Latent TB Infection

Gershon AS, McGeer A, et al. Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis. 2004;39(5):667-72.

Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060-7

McNeill L, Allen M, Estrada C, Cook P. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity. Chest. 2003;123(1):102-106.

White MC, Gournis E, Kawamura M, Menendez E, Tulsky JP. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis. Jan 2003;7(1):30-35.

References

Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099-1104

Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007;167(4):335-342

Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population. Am J Respir Crit Care Med 2008;177: 348-355.

Brassard P, Kezouh A, Suissa S. Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis. 2006 ;43(6):717-722.

Cain KP, Benoit SR, Wonston CA, Mac Kenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA 2008;300(4):405-412.

Centers for Disease Control and Prevention. Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection — United States, 2003. MMWR. 2003;52:735-739.

Chiang C, Slama K, and Enarson D. Associations between tobacco and tuberculosis. Int J Tuberc Lung Dis.; 11(3):258-262

Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis. 1999 Oct;3(10):847-850

Gossec L, et al. Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis. 2009; 68:1680-1685

Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060-2067

International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555-564

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008 Jul 15;5(7):e152

Lin H, Ezzati M, and Murray M. Tobacco smoke, indoor pollution, and tuberculosis: a systematic review and meta-analysis. PLoS Med 2007; 4(1): 173-189.

Nolan, C. M., S. V. Goldberg, and S. E. Buskin. 1999. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 281:1014-1018.

Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med. 2008;149(3):177-184

Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007;11(10):1049-1061